Junjie Li

Challenges to effective cancer control in China, India, and Russia

Paul E. Goss, Kathrin Strasser‐Weippl, Brittany Bychkovsky et al. · The Lancet Oncology · 2014 · 504 citations

Public Health, Health Policy, Oncology +12

Adjuvant Capecitabine With Docetaxel and Cyclophosphamide Plus Epirubicin for Triple-Negative Breast Cancer (CBCSG010): An Open-Label, Randomized, Multicenter, Phase III Trial

Junjie Li, Ke‐Da Yu, Da Pang et al. · Journal of Clinical Oncology · 2020 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Famitinib with Camrelizumab and Nab-Paclitaxel for Advanced Immunomodulatory Triple-Negative Breast Cancer (FUTURE-C-Plus): An Open-Label, Single-Arm, Phase II Trial

Li Chen, Yi‐Zhou Jiang, Song‐Yang Wu et al. · Clinical Cancer Research · 2022 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

Optimising first-line subtyping-based therapy in triple-negative breast cancer (FUTURE-SUPER): a multi-cohort, randomised, phase 2 trial

Lei Fan, Zhonghua Wang, Linxiaoxi Ma et al. · The Lancet Oncology · 2024 · 64 citations

Medicine, Oncology, Breast Oncology +8

Development of High-Resolution Dedicated PET-Based Radiomics Machine Learning Model to Predict Axillary Lymph Node Status in Early-Stage Breast Cancer

Jingyi Cheng, Caiyue Ren, Guangyu Liu et al. · Cancers · 2022 · 44 citations · Full text

Medicine, Oncology, Radiology +17